Spencer Ryan
SEC insider (Form 3/4/5 filer). CIK 0001777938. CEO and Director at DYNAVAX TECHNOLOGIES CORP (DVAX) and 1 other issuer. 22 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in EMERYVILLE, CA.
Companies Spencer Ryan has filed insider reports for
- DYNAVAX TECHNOLOGIES CORP (DVAX): Director, Officer, CEO and Director
- Cidara Therapeutics, Inc. (CDTX): Director
Spencer Ryan
CIK: 0001777938
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
Tender OfferDirect379.6K shares- - Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
DispositionDirect165K shares- - Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
AwardDirect165K shares- - Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
AwardDirect136K shares- - Feb 10, 2026DVAX
DYNAVAX TECHNOLOGIES CORP
DispositionDirect136K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
2.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
11.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
4.3K shares- - Dec 24, 2025DVAX
DYNAVAX TECHNOLOGIES CORP
Tax PaymentDirect138.2K shares at avg. $15.38$2.1M - Dec 23, 2025DVAX
DYNAVAX TECHNOLOGIES CORP
ExerciseDirect45.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 |  DVAX DYNAVAX TECHNOLOGIES CORP | Tender Offer | 379,620 | - | $0 | Direct |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | Disposition | 165,000 | - | $0 | Direct |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | Award | 165,000 | - | $0 | Direct |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | Award | 136,000 | - | $0 | Direct |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | Disposition | 136,000 | - | $0 | Direct |
| Jan 7, 2026 |  CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 2,125 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 11,100 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 4,250 | - | - | Direct |
| Dec 24, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | Tax Payment | 138,168 | $15.38 | $2,125,024 | Direct |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | Exercise | 45,333 | - | - | Direct |
1-10 of 22 transactions